✦ LIBER ✦

Secukinumab efficacy and safety outcomes from a phase II subcutaneous dose-ranging study in the treatment of moderate to severe plaque psoriasis

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adalimumab efficacy and safety in patien

✍ Diana M. Chen; Kenneth Gordon; Craig Leonardi; M.Alan Menter 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Efficacy and safety results of secukinum

📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Adalimumab in Japanese patients with mod

✍ Akihiko ASAHINA; Hidemi NAKAGAWA; Takafumi ETOH; Mamitaro OHTSUKI; THE ADALIMUMA 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 490 KB

Efficacy and safety of efalizumab in pat

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

A 12-week phase 3 study of efficacy and

📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 52 KB

A long-term, open-label study of the saf

✍ Alan Menter; Deborah Lew-Kaya; Frederick Beddingfield; Patricia S. Walker 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 57 KB